| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $3.07M | $2.56M | $1.27M | $15.02M | $34.68M |
| R&D | – | – | – | – | – |
| SG&A | $158.17K | $93.92K | $176.87K | $1.11M | $301.54K |
| Operating Income | -$3.07M | -$2.56M | -$1.15M | -$15.02M | -$34.68M |
| Interest Expense | – | $50.08K | $23.25K | $35.26K | $151.20K |
| Tax Expense | – | – | – | – | – |
| Net Income | -$3.30M | -$2.64M | -$1.31M | -$21.02M | -$34.81M |
| EPS (basic) | 0.0000 | -0.0100 | 0.0000 | – | – |
| EPS (diluted) | 0.0000 | -0.0100 | 0.0000 | – | – |
| Shares (diluted) | $667.06M | $454.40M | $387.15M | – | – |